AKB-9090
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AKB-9090, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: SAD and MAD Study of AKB-9090 in Healthy Adult Participants [Phase 1]